ANLON HEALTHCARE LIMITED (AHCL) financials

ANLON HEALTHCARE LIMITED (AHCL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]

Market Cap: ₹1,427Cr.
Current Price: ₹26.8
Stock P/E: 49.1
ROE: 19.2%
ROCE: 22.4%
Book Value: ₹3.95
Dividend Yield: 0.00%
52W High / Low: ₹37.6/10.3

In Jun 2026, ANLON HEALTHCARE LIMITED (AHCL) reported sales ₹30.98 Cr and net profit ₹4.80 Cr.

Annual TTM: sales ₹174 Cr, net profit ₹29 Cr.

Shareholding: Promoters 52.68% (Jun 2026), FIIs 1.67% (Jun 2026), DIIs 1.23% (Jun 2026), Public 44.43% (Jun 2026), No. of Shareholders 34,671% (Jun 2026).

AHCL quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	24.17	9.36	48.93	33.30	52.20	35.58	55.42	30.98
Expenses	16.65	8.78	31.74	27.06	38.46	23.30	41.51	23.52
Operating Profit	7.52	0.58	17.19	6.24	13.74	12.28	13.91	7.46
OPM %	31.11%	6.20%	35.13%	18.74%	26.32%	34.51%	25.10%	24.08%
Other Income	0.05	0.02	0.04	0.01	0.03	0.20	0.01	0.06
Interest	0.93	0.89	0.91	0.82	0.87	1.51	1.18	0.96
Depreciation	0.47	0.00	0.83	0.43	0.45	0.35	0.13	0.66
Profit before tax	6.17	-0.29	15.49	5.00	12.45	10.62	12.61	5.90
Tax %	57.86%	758.62%	-7.49%	29.20%	25.14%	51.41%	22.36%	18.64%
Net Profit	2.59	-2.49	16.65	3.55	9.32	5.15	9.79	4.80
EPS in Rs	0.06	-0.06	0.42	0.09	0.18	0.10	0.18	0.09
Raw PDF	—	—	—	—	—	—	—	—

AHCL profit and loss (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	16	57	113	66	120	176	174
Expenses	21	52	100	51	88	130	127
Operating Profit	-5	6	13	16	32	46	47
OPM %	-32%	10%	11%	24%	27%	26%	27%
Other Income	0	0	0	0	0	0	0
Interest	3	4	4	4	4	4	5
Depreciation	2	2	2	2	2	1	2
Profit before tax	-10	-0	7	10	27	41	42
Tax %	3%	0%	17%	1%	24%	32%	—
Net Profit	-10	-0	6	10	21	28	29
EPS in Rs	-0.85	-0.01	0.48	0.60	0.51	0.52	0.55
Dividend Payout %	0%	0%	0%	0%	0%	0%	—

AHCL balance sheet (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12	12	12	16	40	53
Reserves	-10	-10	-5	5	41	157
Borrowings	54	62	70	81	67	46
Other Liabilities	16	21	34	26	34	62
Total Liabilities	71	85	112	128	181	317
Fixed Assets	29	27	26	27	23	40
CWIP	0	0	0	0	0	0
Investments	0	2	4	1	1	10
Other Assets	43	56	82	100	158	267
Total Assets	71	85	112	128	181	317

AHCL cash flows (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-15	-2	-3	-3	-22	-36
Cash from Investing Activity	-2	-0	-0	-3	2	-28
Cash from Financing Activity	16	3	2	8	19	76
Net Cash Flow	-2	1	-1	2	-1	12
Free Cash Flow	-15	-2	-3	-7	-19	-55
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	291%	-32%	-23%	-21%	-85%	-69%

AHCL shareholding pattern (%)
Category	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	52.68%	52.68%	52.68%	52.68%
FIIs	0.00%	0.23%	0.32%	1.67%
DIIs	2.83%	4.49%	4.60%	1.23%
Public	44.49%	42.60%	42.40%	44.43%
No. of Shareholders	12,464	11,412	12,484	34,671

AHCL key ratios
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	132	130	142	213	228	215
Inventory Days	669	225	112	452	246	245
Days Payable	409	128	105	217	96	128
Cash Conversion Cycle	392	226	149	448	377	332
Working Capital Days	185	163	122	261	292	321
ROCE %	—	7%	15%	15%	25%	22%

AHCLUpdated 18 Oct 2026, 2:41

Anlon Healthcare Limited

AHCLUpdated 18 Oct 2026, 2:41

Market Cap

₹1,427Cr.

Current Price

₹26.8

High / Low

₹37.6/10.3

Stock P/E

49.1

ROE19.2%

ROCE22.4%

Book Value₹3.95

Face Value₹2.00

Dividend Yield0.00%

About

Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2024	37.83	0.98	30.98	0.06	0.47	5.46	16.85	4.54	0.28
Sep 2024	24.17	0.93	16.65	0.05	0.47	6.17	57.86	2.59	0.06
Dec 2024	9.36	0.89	8.78	0.02	0	-0.29	758.62	-2.49	-0.06
Mar 2025	48.93	0.91	31.74	0.04	0.83	15.49	-7.49	16.65	0.42
Jun 2025	33.3	0.82	27.06	0.01	0.43	5	29.2	3.55	0.09
Sep 2025	52.2	0.87	38.46	0.03	0.45	12.45	25.14	9.32	0.18
Dec 2025	35.58	1.51	23.3	0.2	0.35	10.62	51.41	5.15	0.1
Mar 2026	55.42	1.18	41.51	0.01	0.13	12.61	22.36	9.79	0.18
Jun 2026	30.98	0.96	23.52	0.06	0.66	5.9	18.64	4.8	0.09

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2021	16	3	21	2	-10	3	-10	-0.85
Mar 2022	57	4	52	2	0	0	0	-0.01
Mar 2023	113	4	100	2	7	17	6	0.48
Mar 2024	66	4	51	2	10	1	10	0.6
Mar 2025	120	4	88	2	27	24	21	0.51
Mar 2026	176	4	130	1	41	32	28	0.52
TTM	174	5	127	2	42	—	29	0.55

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	52.68%
FIIs	1.67%
DIIs	1.23%
Public	44.43%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2025	52.68%	0%	2.83%	44.49%
Dec 2025	52.68%	0.23%	4.49%	42.6%
Mar 2026	52.68%	0.32%	4.6%	42.4%
Jun 2026	52.68%	1.67%	1.23%	44.43%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	Investments	Other Assets	Total Assets
Mar 2021	12	-10	54	16	71	29	0	43	71
Mar 2022	12	-10	62	21	85	27	2	56	85
Mar 2023	12	-5	70	34	112	26	4	82	112
Mar 2024	16	5	81	26	128	27	1	100	128
Mar 2025	40	41	67	34	181	23	1	158	181
Mar 2026	53	157	46	62	317	40	10	267	317

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2021	-15	-2	16	-2
Mar 2022	-2	0	3	1
Mar 2023	-3	0	2	-1
Mar 2024	-3	-3	8	2
Mar 2025	-22	2	19	-1
Mar 2026	-36	-28	76	12

Key ratios

Historical financial ratios

Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	132	130	142	213	228	215
Inventory Days	669	225	112	452	246	245
Days Payable	409	128	105	217	96	128
Cash Conversion Cycle	392	226	149	448	377	332
Working Capital Days	185	163	122	261	292	321
ROCE %	—	7%	15%	15%	25%	22%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ANLON HEALTHCARE LIMITED (AHCL)?

The reported market capitalisation for ANLON HEALTHCARE LIMITED (AHCL) is ₹1,427Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of AHCL?

The current price shown for ANLON HEALTHCARE LIMITED (AHCL) on Fincrux is ₹26.8 with a 52-week high/low of ₹37.6/10.3.

What is the P/E ratio of ANLON HEALTHCARE LIMITED (AHCL)?

The stock P/E for ANLON HEALTHCARE LIMITED (AHCL) is 49.1 on Fincrux, with ROE at 19.2% and ROCE at 22.4%.

What were AHCL latest quarterly results?

For Jun 2026, ANLON HEALTHCARE LIMITED (AHCL) reported sales ₹30.98 Cr and net profit ₹4.80 Cr (figures in ₹ crore unless noted).

What are AHCL annual sales and net profit?

For TTM, ANLON HEALTHCARE LIMITED (AHCL) shows sales of ₹174 Cr and net profit of ₹29 Cr on the Fincrux profit & loss statement.

Who owns ANLON HEALTHCARE LIMITED (AHCL)?

Latest shareholding for ANLON HEALTHCARE LIMITED (AHCL) on Fincrux: Promoters 52.68% (Jun 2026), FIIs 1.67% (Jun 2026), DIIs 1.23% (Jun 2026), Public 44.43% (Jun 2026), No. of Shareholders 34,671% (Jun 2026).

Where can I find ANLON HEALTHCARE LIMITED (AHCL) financials?

ANLON HEALTHCARE LIMITED (AHCL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show AHCL balance sheet and cash flow?

Yes. The ANLON HEALTHCARE LIMITED (AHCL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 2:41